Literature DB >> 2437329

Changes in the VIPergic, cholinergic and adrenergic innervation of human penile tissue in diabetic and non-diabetic impotent males.

J Lincoln, R Crowe, P F Blacklay, J P Pryor, J S Lumley, G Burnstock.   

Abstract

Penile tissue (consisting of corpus cavernosum and tunica albuginea) was obtained from 19 patients undergoing surgery for the implantation of penile prostheses. The tissue was examined for vasoactive intestinal polypeptide-like immunoreactivity in nerves, acetylcholinesterase-positive staining in nerves and noradrenaline content. Impotence was due to a variety of causes; 11 patients were classified as a 'non-neuropathic' group on the basis of their clinical history which included Peyronie's disease, vascular disease, hypertension and psychogenic impotence. Vasoactive intestinal polypeptide-like immunoreactive and acetylcholinesterase-positive nerves were present and the pattern and distribution were similar in each patient in this group. The noradrenaline content of the tunica albuginea was significantly lower than the corpus cavernosum (p less than 0.02), although there was a linear relationship between the noradrenaline contents of the two regions (r = 0.95, p less than 0.01). By comparison, a complete absence of vasoactive intestinal polypeptide-like immunoreactivity in nerves was observed in a patient with a cauda equina lesion. Five out of six diabetic patients studied revealed a marked reduction in vasoactive intestinal polypeptide-like immunoreactivity in nerves associated with the cavernous smooth muscle, while acetylcholinesterase-positive staining was reduced in three out of five diabetic patients studied. The noradrenaline content of the corpus cavernosum from diabetic patients was significantly lower (p less than 0.02) than that of the 'non-neuropathic' group. The noradrenaline content of the tunica albuginea, however, was similar in both groups. The results provide evidence that VIPergic, cholinergic and adrenergic nerves in the penis are affected in diabetes mellitus and thus may contribute to the development of impotence in diabetic patients.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2437329     DOI: 10.1016/s0022-5347(17)44358-8

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


  9 in total

Review 1.  Regulation of tone in penile cavernous smooth muscle. Established concepts and new findings.

Authors:  K E Andersson; F Holmquist
Journal:  World J Urol       Date:  1994       Impact factor: 4.226

2.  Evaluation of impotent men with intracorporeal injection of papaverine and colour Doppler ultrasound.

Authors:  M Cetinkaya; E Erdoğan; A Memiş; B Oztürk; S Koçak
Journal:  Int Urol Nephrol       Date:  1995       Impact factor: 2.370

3.  Selective nitrergic neurodegeneration in diabetes mellitus - a nitric oxide-dependent phenomenon.

Authors:  S Cellek; J Rodrigo; E Lobos; P Fernández; J Serrano; S Moncada
Journal:  Br J Pharmacol       Date:  1999-12       Impact factor: 8.739

4.  Neural regulation of sexual function in men.

Authors:  Kazem M Azadzoi; Jinghua Yang; Mike B Siroky
Journal:  World J Clin Urol       Date:  2013-11-24

Review 5.  Erectile dysfunction and diabetes.

Authors:  Neelima V Chu; Steven V Edelman
Journal:  Curr Diab Rep       Date:  2002-02       Impact factor: 4.810

6.  Evidence against vasoactive intestinal polypeptide as the relaxant neurotransmitter in human cavernosal smooth muscle.

Authors:  R S Pickard; P H Powell; M A Zar
Journal:  Br J Pharmacol       Date:  1993-02       Impact factor: 8.739

7.  Clinical reliability of multi-drug intracavernous vasoactive pharmacotherapy for diabetic impotence.

Authors:  F Montorsi; G Guazzoni; F Bergamaschi; M Zucconi; P Rigatti; G Pizzini; A Miani; G Pozza
Journal:  Acta Diabetol       Date:  1994-04       Impact factor: 4.280

8.  Pituitary adenylate cyclase-activating polypeptide, helospectin, and vasoactive intestinal polypeptide in human corpus cavernosum.

Authors:  P Hedlund; P Alm; P Ekström; J Fahrenkrug; J Hannibal; H Hedlund; B Larsson; K E Andersson
Journal:  Br J Pharmacol       Date:  1995-10       Impact factor: 8.739

9.  Adenosine actions are preserved in corpus cavernosum from obese and type II diabetic db/db mouse.

Authors:  Fernando Silva Carneiro; Fernanda R C Giachini; Victor V Lima; Zidonia N Carneiro; Romulo Leite; Edward W Inscho; Rita C Tostes; R Clinton Webb
Journal:  J Sex Med       Date:  2008-01-21       Impact factor: 3.802

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.